There is no evidence that DHEA  improves quality of life but there is some evidence that it is associated with and rogenic side effects .
There is uncertainty whether DHEA decreases menopausal symptoms , but DHEA may slightly improve sexual function compared with placebo
BACKGROUND During menopause a decreasing ovarian follicular response generally causes a fluctuation and eventual decrease in estrogen levels .
This can lead to the development of various perimenopausal and postmenopausal symptoms ( for example hot flushes , night sweats , vaginal dryness ) .
Dehydroepi and rosterone ( DHEA ) is one of the main precursors of and rogens , which in turn are converted to testosterone and estrogens .
It is possible that the administration of DHEA may increase estrogen and testosterone levels in peri- and postmenopausal women to alleviate their symptoms and improve general wellbeing and sexual function ( for example libido , dyspareunia , satisfaction ) .
Treatment with DHEA is controversial as there is uncertainty about its effectiveness and safety .
This review should clearly outline the evidence for DHEA in the treatment of menopausal symptoms and evaluate its effectiveness and safety by combining the results of r and omised controlled trials .
OBJECTIVES To assess the effectiveness and safety of administering DHEA to women with menopausal symptoms in the peri- or postmenopausal phase .
Acute dehydroepiandrosterone (DHEA) effects on sexual arousal in postmenopausal women.
BACKGROUND The age-related decline of dehydroepi and rosterone ( DHEA ) has prompted research on its experimental replacement in women . Although no relationship to sexual functioning in healthy women has been shown to date , DHEA replacement has potential for affecting sexual response . METHODS To investigate DHEA effects , 16 sexually functional postmenopausal women participated in a r and omized , double-blind , crossover protocol in which oral administration of DHEA ( 300 mg ) or placebo occurred 60 minutes before the presentation of an erotic video segment . Blood DHEA sulfate ( DHEAS ) changes , subjective and physiological sexual responses , as well as affective responses were measured in response to videotaped neutral and erotic video segments . RESULTS The concentration of DHEAS increased 2 - 5-fold following DHEA administration in all 16 women . Subjective ratings across DHEA and placebo conditions showed significantly greater mental ( p < 0.016 ) and physical ( p < 0.036 ) sexual arousal to the erotic video with DHEA vs. placebo .  Positive affect also increased during the erotic video across drug conditions . Vaginal pulse amplitude ( VPA ) and vaginal blood volume ( VBV ) demonstrated a significant increase ( p < 0.001 ) between neutral and erotic film segments within both conditions ( DHEA and placebo ) but did not differentiate drug conditions . CONCLUSION In sum , increases in mental and physical sexual arousal ratings significantly increased in response to an acute dose of DHEA in postmenopausal women
There is no evidence that DHEA  improves quality of life but there is some evidence that it is associated with and rogenic side effects .
There is uncertainty whether DHEA decreases menopausal symptoms , but DHEA may slightly improve sexual function compared with placebo
BACKGROUND During menopause a decreasing ovarian follicular response generally causes a fluctuation and eventual decrease in estrogen levels .
This can lead to the development of various perimenopausal and postmenopausal symptoms ( for example hot flushes , night sweats , vaginal dryness ) .
Dehydroepi and rosterone ( DHEA ) is one of the main precursors of and rogens , which in turn are converted to testosterone and estrogens .
It is possible that the administration of DHEA may increase estrogen and testosterone levels in peri- and postmenopausal women to alleviate their symptoms and improve general wellbeing and sexual function ( for example libido , dyspareunia , satisfaction ) .
Treatment with DHEA is controversial as there is uncertainty about its effectiveness and safety .
This review should clearly outline the evidence for DHEA in the treatment of menopausal symptoms and evaluate its effectiveness and safety by combining the results of r and omised controlled trials .
OBJECTIVES To assess the effectiveness and safety of administering DHEA to women with menopausal symptoms in the peri- or postmenopausal phase .